ANTIGEN INTERNATIONAL
Antigen International is markets and distributes pharmaceutical products.
ANTIGEN INTERNATIONAL
Industry:
Marketing Pharmaceutical Wholesale
Founded:
1963-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Status:
Active
Similar Organizations
Amarox Pharma
Amarox Pharma markets and distributes pharmaceuticals.
Azanta
Azanta is markets and distributes pharmaceutical products.
Ciclum Farma, Unipessoal
Ciclum Farma, Unipessoal is markets and distributes pharmaceutical products.
Neuca
NEUCA is a group of financially connected companies offering a wide spectrum of services and products on the healthcare market.
SIA International
SIA International is one of the five biggest pharmaceutical distributors in the country.
More informations about "Antigen International"
WHO International Standard for evaluation of the …
Oct 26, 2021 The first WHO International Standard and International Reference Panel for anti-SARS-CoV-2 immunoglobulin were established by the WHO Expert Committee on Biological Standardization in December, 2020. The WHO …See details»
Antigen-detection in the diagnosis of SARS-CoV-2 …
Oct 5, 2021 This interim guidance offers general recommendations for selection of antigen-detecting rapid diagnostic tests (Ag-RDTs) and key considerations for their implementation. ... International Health Regulations; Independent …See details»
WHO International Standard 8. PREPARATION AND TRANSFER OF …
Reference reagents for prostate-specific antigen (PSA): establishment of the First International Standards for free PSA and PSA (90:10). Clin Chem 46(9): 1310-1317. 4. Sensabaugh G.F. & Blake E.T. Seminal plasma protein p30: simplified purification and evidence for identity with prostate-specific antigen. J Urol 1990 144: 1523-6 5.See details»
Antigen-detection in the diagnosis of SARS-CoV-2 infection
Oct 6, 2021 A new technology for COVID-19 detection has become available that is much simpler and faster to perform that currently-recommended nucleic acid amplification tests (NAAT), like PCR. This method relies on direct detection of SARS-CoV-2 viral proteins in nasal swabs and other respiratory secretions using a lateral flow immunoassay (also called an RDT) that gives …See details»
Establishment of the WHO International Standard and Reference …
Nov 17, 2020 should be addressed to the World Health Organization, 1211 Geneva 27, Switzerland, attention: ... inhibitory assays and one Double Antigen Binding Assay. The candidate preparation, sample G, NIBSC code 20/136, was assessed as part of a blinded ... International Concern on 30th January 2020, and a Pandemic on 11th March 2020. On 25thSee details»
Antigen-detection in the diagnosis of SARS -CoV-2 infection
• Antigen-detecting diagnostic testing uses upper respiratory specimens or saliva to test for SARS-CoV-2 infection by detecting viral proteins (e.g., nucleoprotein). • Antigen-detecting rapid diagnostic t ests (Ag-RDTs) can offer a faster and lessexpensive way to diagnose active SARS-CoV-2 infection thanSee details»
EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION
Jan 16, 2023 SARS-CoV-2 antigen preparations as potential source materials for a candidate WHO International Standard for SARS-CoV-2 antigen, using a range of antigen tests. Samples of SARS-CoV-2 antigen were prepared from cell culture-grown virus inactivated using different physical and chemical methods and recombinant SARS-CoV-2 N and S proteins. TheSee details»
The WHO International Standard for COVID-19 serological tests
The aim of the World Health Organization (WHO) first International Standard (IS) for anti-SARS-CoV-2 immunoglobulin is to harmonize humoral immune response assessment after natural infection or vaccination, and recommend reporting the results for binding activity in Binding Antibody Units (BAU). ... with the lowest agreement values for kits ...See details»
WHO International Standard for anti-SARS-CoV-2 immunoglobulin
Apr 10, 2021 WHO International Standard for anti-SARS-CoV-2 immunoglobulin. WHO International Standard for anti-SARS-CoV-2 immunoglobulin Lancet. 2021 Apr 10;397(10282) :1347 ... World Health Organization Substances Antibodies, Viral COVID-19 Vaccines ...See details»
WHO/BS/2022.2426: A Collaborative Study to Evaluate the …
Jul 19, 2022 Publications of the World Health Organization. Skip to main content. Global; ... A Collaborative Study to Evaluate the Proposed 1st WHO International Standard for SARS-CoV-2 Antigen. 19 July 2022 ... The performance of the candidate was evaluated as part of a panel of nine samples using 18 different SARS-CoV-2 antigen detection tests comprising ...See details»
Antigen-detection in the diagnosis of SARS-CoV-2 infection using …
World Health Organization. (2020). Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays: interim guidance, 11 September 2020.See details»
WHO International Standard for evaluation of the antibody
The first WHO International Standard and International Reference Panel for anti-SARS-CoV-2 immunoglobulin were established by the WHO Expert Committee on Biological Standardization in December, 2020. The WHO International Antibody Standards are intended to serve as global reference reagents, against which national reference preparations or secondary standards can …See details»
The importance of using WHO International Standards to …
Institutions and used the International Standard to har-monise the data. Although some degree of variability was present, the results showed that the International Standard couldbeusedtoharmoniseIgG,pan-IgG,andtotal-IgGdata for different antigens (including SARS-CoV-2 spike, RBD, and N) from different assays.17 Harmonisation is feasible and ...See details»
The importance of using WHO International Standards to ... - The …
Jan 12, 2024 The International Standard was assigned a potency of 250 IU/lyophilised ampoule for neutralizing antibody activity. 10, 11 Additionally, the International Standard could be used to compare binding antibody assays (provided the assays detect antibodies of the same class and against the same antigen), using the reference’s designated 250 binding antibody units …See details»
WHO International Standard for evaluation of the antibody …
Mar 1, 2022 The development of measurement standards involves elaborate collaborative studies in numerous laboratories worldwide. As examples of the measurement standards for COVID-19, the first WHO International Standard for anti-SARS-CoV-2 immunoglobulin with an assigned unitage of 250 International Units (IU) per ampoule (neutralising antibody activity) …See details»
Antigen Detection Tests for SARS-CoV-2: a systematic review and …
May 11, 2022 The ongoing SARS-CoV-2 pandemic, and particularly its resurgence during European Winter Season, has urged international health authorities to assess the extensive implementation of RAD tests in the diagnostic procedures for SARS-CoV-2 (13,31,41,43–45). Because of the increasing surge of intensive care during the later stages of COVID-19 ...See details»
Advice on the use of point-of-care immunodiagnostic tests for …
Apr 8, 2020 Since this brief was published, WHO has updated its advice and released guidance on the use of antigen detection rapid diagnostic tests.Please refer to that document for our latest position on these tests. In response to the growing COVID-19 pandemic and shortages of laboratory-based molecular testing capacity and reagents, multiple diagnostic test …See details»
WHO international standard for SARS-CoV-2 antibodies to
WHO international standard for SARS-CoV-2 antibodies to determine markers of protection Lancet Microbe . 2022 Feb;3(2):e81-e82. doi: 10.1016/S2666-5247(21)00307-4.See details»
US Department of Labor, International Labour Organization renew ...
2 days ago WASHINGTON – The U.S. Department of Labor today announced that its Women’s Bureau renewed a memorandum of understanding with the International Labour Organization office for the United States and Canada to continue working together to end gender-based violence and harassment in the world of work.. The renewed agreement aims to strengthen …See details»
Global partnership to make available 120 million affordable, …
Sep 28, 2020 A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries, catalytic funding to assist governments to deploy the tests and an initial US$50 million procurement fundSeveral rapid, point-of-care antigen tests are being assessed by WHO for …See details»